The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
Goodwin J, Neugent ML, Lee SY, Choe JH, Choi H, Jenkins DMR, Ruthenborg RJ, Robinson MW, Jeong JY, Wake M, Abe H, Takeda N, Endo H, Inoue M, Xuan Z, Yoo H, Chen M, Ahn JM, Minna JD, Helke KL, Singh PK, Shackelford DB, Kim JW.
Goodwin J, et al. Among authors: chen m.
Nat Commun. 2017 May 26;8:15503. doi: 10.1038/ncomms15503.
Nat Commun. 2017.
PMID: 28548087
Free PMC article.